The document discusses implementing a Sickle Cell Vulnerability Assessment (SCVA) to improve care for sickle cell disease patients. It notes disparities in care for this vulnerable population and cites regulatory drivers and benchmarks supporting standardized assessment. A proposed SCVA methodology would assess medical history, vulnerabilities, and pain for individualized care plans. Implementing the SCVA using Lewin's change model and PDCA cycles is outlined over six weeks, with strategies including staff education and surveys to evaluate outcomes.
Related topics: